Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombotic Microangiopathies | 1 | 2021 | 2 | 0.690 |
Why?
|
| Dyspnea | 1 | 2021 | 6 | 0.690 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 2 | 0.680 |
Why?
|
| Infection Control | 1 | 2021 | 8 | 0.680 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 5 | 0.680 |
Why?
|
| Health Personnel | 1 | 2021 | 49 | 0.660 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 45 | 0.660 |
Why?
|
| Lung | 1 | 2021 | 106 | 0.620 |
Why?
|
| Middle Aged | 5 | 2026 | 2108 | 0.310 |
Why?
|
| Female | 5 | 2026 | 4060 | 0.250 |
Why?
|
| Respiratory Insufficiency | 1 | 2026 | 9 | 0.240 |
Why?
|
| Hypoxia | 1 | 2026 | 37 | 0.240 |
Why?
|
| Humans | 6 | 2026 | 6794 | 0.220 |
Why?
|
| Time Factors | 2 | 2021 | 321 | 0.190 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 1 | 0.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 3 | 0.180 |
Why?
|
| Dermatomyositis | 1 | 2021 | 2 | 0.180 |
Why?
|
| Melanoma | 1 | 2021 | 14 | 0.180 |
Why?
|
| Biopsy | 1 | 2021 | 36 | 0.170 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 7 | 0.170 |
Why?
|
| Personal Protective Equipment | 1 | 2021 | 4 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 57 | 0.170 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 79 | 0.170 |
Why?
|
| Focus Groups | 1 | 2021 | 46 | 0.170 |
Why?
|
| Male | 4 | 2026 | 3671 | 0.170 |
Why?
|
| Quality Improvement | 1 | 2021 | 31 | 0.170 |
Why?
|
| Disease Progression | 1 | 2021 | 170 | 0.160 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 268 | 0.160 |
Why?
|
| Anesthesia | 1 | 2019 | 8 | 0.150 |
Why?
|
| Analgesia | 1 | 2019 | 16 | 0.150 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 19 | 0.150 |
Why?
|
| Critical Illness | 1 | 2019 | 14 | 0.150 |
Why?
|
| Pain | 1 | 2019 | 38 | 0.150 |
Why?
|
| Adult | 2 | 2021 | 2113 | 0.140 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 2 | 0.130 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 3 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 5 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 23 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 21 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 50 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2026 | 44 | 0.100 |
Why?
|
| Aged | 3 | 2026 | 1539 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2026 | 45 | 0.060 |
Why?
|
| Phenotype | 1 | 2026 | 91 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2026 | 331 | 0.060 |
Why?
|
| Biomarkers | 1 | 2026 | 214 | 0.060 |
Why?
|
| United States | 1 | 2026 | 1019 | 0.050 |
Why?
|
| Propofol | 1 | 2019 | 3 | 0.040 |
Why?
|
| Fentanyl | 1 | 2019 | 7 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 13 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2019 | 17 | 0.040 |
Why?
|
| Pain Management | 1 | 2019 | 27 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 84 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 89 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 58 | 0.040 |
Why?
|
| California | 1 | 2019 | 230 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 1 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2017 | 2 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2017 | 3 | 0.030 |
Why?
|
| Leucovorin | 1 | 2017 | 3 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2017 | 4 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2017 | 8 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 24 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 42 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 497 | 0.030 |
Why?
|